These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 18977106

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Study of forced decomposition behavior of lamivudine using LC, LC-MS/TOF and MS(n).
    Bedse G, Kumar V, Singh S.
    J Pharm Biomed Anal; 2009 Jan 15; 49(1):55-63. PubMed ID: 19022602
    [Abstract] [Full Text] [Related]

  • 43. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
    Görög S.
    Acta Pharm Hung; 2000 Jan 15; 70(3-6):131-7. PubMed ID: 11379019
    [Abstract] [Full Text] [Related]

  • 44. Identification of pharmaceutical impurities in formulated dosage forms.
    Pan C, Liu F, Motto M.
    J Pharm Sci; 2011 Apr 15; 100(4):1228-59. PubMed ID: 24081463
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).
    Borman PJ, Chatfield MJ, Crowley EL, Eckers C, Elder DP, Francey SW, Laures AM, Wolff JC.
    J Pharm Biomed Anal; 2008 Dec 01; 48(4):1082-9. PubMed ID: 18835674
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Liquid chromatography mass spectrometry of dexamethasone and betamethasone.
    Cairns T, Siegmund EG, Stamp JJ, Skelly JP.
    Biomed Mass Spectrom; 1983 Mar 01; 10(3):203-8. PubMed ID: 6850073
    [Abstract] [Full Text] [Related]

  • 50. Development and validation of a stability-indicating RP-HPLC method to separate low levels of dexamethasone and other related compounds from betamethasone.
    Xiong Y, Xiao KP, Rustum AM.
    J Pharm Biomed Anal; 2009 Apr 05; 49(3):646-54. PubMed ID: 19171447
    [Abstract] [Full Text] [Related]

  • 51. Isolation and characterization of degradation products of moxidectin using LC, LTQ FT-MS, H/D exchange and NMR.
    Awasthi A, Razzak M, Al-Kassas R, Greenwood DR, Harvey J, Garg S.
    Anal Bioanal Chem; 2012 Nov 05; 404(8):2203-22. PubMed ID: 22986987
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Separation and identification of degradation products in eprinomectin formulation using LC, LTQ FT-MS, H/D exchange, and NMR.
    Awasthi A, Razzak M, Al-Kassas R, Greenwood DR, Harvey J, Garg S.
    J Pharm Biomed Anal; 2012 Apr 07; 63():62-73. PubMed ID: 22341479
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
    Douša M, Gibala P, Havlíček J, Plaček L, Tkadlecová M, Břicháč J.
    J Pharm Biomed Anal; 2011 Jul 15; 55(5):949-56. PubMed ID: 21481557
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. A systematic approach to development of liquid chromatographic impurity methods for pharmaceutical analysis.
    Stafford JD, Maloney TD, Myers DP, Cintron JM, Castle BC.
    J Pharm Biomed Anal; 2011 Sep 10; 56(2):280-92. PubMed ID: 21665403
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.